- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
Daily deal net: October 21, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Oct 21, 2021Saama cedes majority stake for $430m
Amgen, Merck & Co, Pfizer, Intermountain and McKesson were among the investors to jointly acquire a majority of the clinical trials software producer's shares.
Oct 21, 2021Huahui Health treats itself to $78m
The WuXi AppTec-backed hepatitis specialist replenished its coffers in a series A-plus round led by Hillhouse Capital fund GL Capital.
Oct 21, 2021Daily Deal Round Up: October 20, 2021
MS&AD Ventures and Mouro Capital helped privacy management technology provider Skyflow secure $45m while neurotherapeutics developer Cecerin revealed $40m from investors including Nestlé.
Oct 20, 2021Abbisko nabs $226m in IPO
AstraZeneca, Eli Lilly and Sinopharm all achieved exits as the cancer therapy developer listed on the Hong Kong Stock Exchange at a reported valuation of nearly $1.1bn.
Oct 20, 2021IO Biotech approaches Nasdaq IPO
The cancer immunotherapy developer, which counts Novo and Lundbeck as investors, filed to raise up to $100m in its initial public offering.
Oct 20, 2021Intelerad absorbs Ambra Health
Intelerad has bought the Mayo Clinic-backed medical image software developer to further expand its platform for reading, storing and sharing diagnostic imaging.
Oct 19, 2021Creative Biosciences accrues $87m in series D
Alibaba participated in the cancer diagnostic kit provider's first funding round in over a year, pushing its overall funding past $230m.
Oct 19, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
